BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

AMGEN — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report (No Activity)

AMGEN

via MR. DAN CRIPPEN

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 28, 2026Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: AMGEN
Description: Manufacture Pharmaceuticals
Location: District of Columbia · United States of America

Registrant

Firm: MR. DAN CRIPPEN
Location: Leonardtown, Maryland, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.